Trial intelligence / Profile preview

Chemoradiotherapy Regimens for Locally Advanced Pancreatic Cancer

NCT00049348Phase 2Completed

Sponsor
Eastern Cooperative Oncology Group
Start
Oct 2003
Primary completion
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gemcitabine, fluorouracil, cisplatin in pancreatic adenocarcinoma (PDAC), sponsored by Eastern Cooperative Oncology Group. Started Oct 2003; status: completed.

02

Drugs

gemcitabinefluorouracilcisplatin
03

Conditions

pancreatic adenocarcinoma (PDAC)

Beyond the preview

Go deeper on NCT00049348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00049348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call